Rocket Lab Stock Slides After Piper Sandler Initiates With Neutral Rating

Shares of Rocket Lab (NASDAQ: RKLB) fell more than 3% in pre-market trading after investment bank Piper Sandler initiated coverage of the aerospace company with a Neutral rating, introducing a new layer of caution from Wall Street.

Analyst Initiates Cautious Stance

Piper Sandler set a price target of $83 per share, which offers limited upside from the stock's recent trading levels, according to the research note. The firm's initiation signals a balanced risk-reward profile for the company.

This marks the first non-buy equivalent rating for Rocket Lab among the 16 analysts who cover the stock, as reported by Investing.com. The new analysis acted as a catalyst for renewed selling pressure, pushing the shares down to $73.81 in pre-open activity.

Compounding Headwinds

Ad

The neutral rating crystallized several pre-existing concerns that have weighed on investor sentiment in recent weeks. These factors include:

• Pending Iridium Acquisition: Market anxiety persists over the company's planned ~$8 billion acquisition of Iridium Communications. Investors are weighing the strategic benefits against the risks of share dilution and integration complexity, particularly given the $3.6 billion in committed bridge financing for the deal.
• Insider Selling: The source notes consistent selling of shares by company insiders, including the CFO, in recent months. In contrast, no open-market purchases have been recorded among executives over the past six months.

Broader Market Pressure

The decline in Rocket Lab's stock also occurred amid a wider market downturn, with the tech-heavy Nasdaq falling 1.0% in a risk-off session that disproportionately affects high-growth stocks. The stock is now trading at a more than 50% discount from its 52-week high of $151 and is below its 20-day and 50-day moving averages, indicating weakening technical momentum.